Respiratory Syncytial Virus-related Death in Children With Down Syndrome: The RSV GOLD Study

Yvette N Löwensteyn1, Emily W E M Phijffer1, Juliette V L Simons1

  • 1From the Division of Infectious Diseases, Department of Pediatrics, University Medical Centre Utrecht, Utrecht, The Netherlands.

Insights

Down syndrome (DS) increases the risk of severe respiratory syncytial virus (RSV) infection mortality in children under five. Even without other risk factors, DS poses a significant threat, highlighting the need for targeted prevention strategies beyond maternal vaccination.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Genetics

Background:

  • Respiratory syncytial virus (RSV) is a leading cause of death in children globally.
  • Down syndrome (DS) is an established independent risk factor for severe RSV infection.
  • This study investigates the characteristics of children with DS who died from RSV.

Purpose of the Study:

  • To describe the demographic and clinical features of children with Down syndrome who experienced mortality due to RSV infection.
  • To identify specific risk factors and comorbidities associated with RSV mortality in this population.
  • To inform public health strategies for preventing RSV-related deaths in children with DS.

Main Methods:

  • A retrospective case series design was employed.
  • Data were collected globally through the RSV Global Online Database study.
  • Included were children under five with Down syndrome and laboratory-confirmed RSV infection who died.

Main Results:

  • 53 cases of children with DS and RSV mortality were identified across 20 countries.
  • The median age at death was 6 months; 24.5% had no other risk factors for severe RSV.
  • Congenital heart disease was present in 67.9% of cases; hospitalization was longer compared to children without DS.

Conclusions:

  • Down syndrome is a significant risk factor for RSV-related mortality, even in the absence of other comorbidities.
  • The age distribution of deaths suggests that maternal RSV vaccination alone may not fully protect children with DS.
  • Further research and targeted interventions are needed to reduce RSV mortality in children with Down syndrome.
Abstract

Related Concept Videos

Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
6.0K
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
911
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
372
Acute Respiratory Failure-I01:21

Acute Respiratory Failure-I

Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
709
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
661
Common Respiratory Disorders01:31

Common Respiratory Disorders

Respiratory disorders, a prevalent health concern globally, are generally divided into two primary categories: upper and lower respiratory tract disorders. The categorization is based on the area of the respiratory system they affect.
Upper respiratory disorders impact the airways above the vocal cords, encompassing areas like the nose, sinuses, and throat. Various conditions fall under this category, including the common cold and allergic rhinitis. These disorders can stem from several causes,...
1.2K